Free Trial

AbCellera Biologics (ABCL) SEC Filings & 10K Form

AbCellera Biologics logo
$2.76 +0.09 (+3.37%)
(As of 01:20 PM ET)

Recent AbCellera Biologics SEC Filings

DateFilerForm TypeView
10/09/2024
9:20 AM
AbCellera Biologics (Subject)
BAILLIE GIFFORD & CO (Filed by)
Form SCHEDULE 13G/A
09/24/2024
3:09 PM
AbCellera Biologics (Issuer)
Hansen Carl L. G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
3:35 PM
AbCellera Biologics (Issuer)
Thermopylae Holdings Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:55 PM
AbCellera Biologics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2024
3:26 PM
AbCellera Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/24/2024
5:30 PM
AbCellera Biologics (Issuer)
Hayden Michael R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
5:38 PM
AbCellera Biologics (Issuer)
Lecault Veronique (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
5:19 PM
AbCellera Biologics (Issuer)
Lo Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
5:15 PM
AbCellera Biologics (Issuer)
Montalbano John S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
3:53 PM
AbCellera Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
3:22 PM
AbCellera Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2024
3:47 PM
AbCellera Biologics (Filer)
Form ARS
04/29/2024
3:39 PM
AbCellera Biologics (Filer)
Form DEFA14A
02/27/2024
1:12 PM
AbCellera Biologics (Issuer)
Hansen Carl L. G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
3:49 PM
AbCellera Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2024
3:49 PM
AbCellera Biologics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/20/2024
3:36 PM
AbCellera Biologics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/20/2024
3:27 PM
AbCellera Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2024
10:47 AM
AbCellera Biologics (Subject)
BAILLIE GIFFORD & CO (Filed by)
Form SC 13G/A
01/16/2024
5:14 PM
AbCellera Biologics (Issuer)
Hansen Carl L. G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2024
5:18 PM
AbCellera Biologics (Issuer)
Booth Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2024
5:21 PM
AbCellera Biologics (Issuer)
Stimart Tryn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2024
5:23 PM
AbCellera Biologics (Issuer)
Lecault Veronique (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
5:08 PM
AbCellera Biologics (Issuer)
Thermopylae Holdings Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/28/2023
4:28 PM
AbCellera Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ABCL) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners